Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines

Chin Med J (Engl). 2018 Aug 20;131(16):1891-1893. doi: 10.4103/0366-6999.238134.

Authors

Ning Wang¹, Jie-Ming Qu², Jin-Fu Xu¹

Affiliations

¹ Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
² Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

No abstract available

Keywords: Bronchiectasis; Challenge; China; Disease Management.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use
Bronchiectasis / drug therapy
Bronchiectasis / epidemiology*
Bronchiectasis / etiology
Bronchiectasis / microbiology
China
Ciliary Motility Disorders / drug therapy
Ciliary Motility Disorders / epidemiology
Ciliary Motility Disorders / etiology
Ciliary Motility Disorders / microbiology
Connective Tissue / metabolism
Humans
Immunoglobulins / metabolism
Pseudomonas aeruginosa / drug effects
Pseudomonas aeruginosa / pathogenicity

Substances

Anti-Bacterial Agents
Immunoglobulins